Hostname: page-component-cd9895bd7-jn8rn Total loading time: 0 Render date: 2024-12-28T07:17:17.487Z Has data issue: false hasContentIssue false
  • English
  • Français

Current state of the art for use of pacemakers and defibrillators in patients with congenital cardiac malformations

Published online by Cambridge University Press:  13 October 2006

Elizabeth A. Stephenson  and
Jonathan R. Kaltman
Elizabeth A. Stephenson
Affiliation:
Paediatric Cardiology, The Hospital for Sick Children, Toronto, Ontario, Canada
Jonathan R. Kaltman
Affiliation:
Division of Cardiology, The Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania, United States of America
Get access Rights & Permissions [Opens in a new window]

Abstract

As patients with congenital cardiac malformations increasingly survive therapeutic interventions, and our understanding of primary electrical diseases increases, the landscape of paediatric and congenital electrophysiology is expanding. Electrophysiologic abnormalities, both tachycardic and bradycardic, are commonly seen in post-operative patients with congenital cardiac disease, as well as being part of the natural history of congenital malformations and cardiomyopathies. Disturbances of rhythm represent an increasing morbidity in this population, and therapies using devices in the form of pacemakers and implantable cardioverter-defibrillators have taken on a correspondingly important role. In this review, we discuss some of the key features and recent advances in pacing for bradycardia, resynchronization pacing, anti-tachycardia pacing, and use of implantable cardioverter-defibrillators.

Keywords

Tetralogy of Fallotatrioventricular dissociationabnormalities of cardiac rhythmcardiac resynchronization
Type
Miscellaneous Topics
Information
Cardiology in the Young , Volume 16 , Supplement S3: Controversies and Challenges of the Atrioventricular Junctions and Other Challenges Facing Paediatric Cardiovascular Practitioners and their Patients , September 2006 , pp. 151 - 156
Copyright
© 2006 Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Huhta JC, Maloney JD, Ritter DG, Ilstrup DM, Feldt RH. Complete atrioventricular block in patients with atrioventricular discordance. Circulation 1983; 67: 1374–1377.Google Scholar
Mehta AV, O'Riordan AC, Sanchez GR, Black IF. Acquired nonsurgical complete atrioventricular block in a child with endocardial cushion defect. Clin Cardiol 1982; 5: 603–605.Google Scholar
Anderson RH, Becker AE, Arnold R, Wilkinson JL. The conducting tissues in congenitally corrected transposition. Circulation 1974; 50: 911–923.Google Scholar
Daliento L, Corrado D, Buja G, John N, Nava A, Thiene G. Rhythm and conduction disturbances in isolated, congenitally corrected transposition of the great arteries. Am J Cardiol 1986; 58: 314–318.Google Scholar
Lundstrom U, Bull C, Wyse RK, Somerville J. The natural and “unnatural” history of congenitally corrected transposition. Am J Cardiol 1990; 65: 1222–1229.Google Scholar
Connelly MS, Liu PP, Williams WG, Webb GD, Robertson P, McLaughlin PR. Congenitally corrected transposition of the great arteries in the adult: functional status and complications. [see comment]. J Am Coll Cardiol 1996; 27: 1238–1243.Google Scholar
Gregoratos G, Abrams J, Epstein AE, et al. ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). Circulation 2002; 106: 2145–2161.Google Scholar
Wilkoff BL, Cook JR, Epstein AE, et al. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. [see comment]. JAMA 2002; 288: 3115–3123.Google Scholar
Sweeney MO, Shea JB, Fox V, et al. Randomized pilot study of a new atrial-based minimal ventricular pacing mode in dual-chamber implantable cardioverter-defibrillators. Heart Rhythm 2004; 1: 160–167.Google Scholar
Ragonese P, Guccione P, Drago F, Turchetta A, Calzolari A, Formigari R. Efficacy and safety of ventricular rate responsive pacing in children with complete atrioventricular block. Pacing Clin Electrophysiol 1994; 17(4 Pt 1): 603–610.Google Scholar
Paridon SM, Karpawich PP, Pinsky WW. Exercise performance with single chamber rate-responsive pacing in congenital heart defects after operation. Am J Cardiol 1991; 68: 1231–1233.Google Scholar
Molina JE, Dunnigan AC, Crosson JE. Implantation of transvenous pacemakers in infants and small children. Ann Thorac Surg 1995; 59: 689–694.Google Scholar
Ward DE, Jones S, Shinebourne EA. Long-term transvenous pacing in children weighing ten kilograms or less. Int J Cardiol 1987; 15: 112–115.Google Scholar
Figa FH, McCrindle BW, Bigras JL, Hamilton RM, Gow RM. Risk factors for venous obstruction in children with transvenous pacing leads. Pacing Clin Electrophysiol 1997; 20(8 Pt 1): 1902–1909.Google Scholar
Cutler NG, Karpawich PP, Cavitt D, Hakimi M, Walters HL. Steroid-eluting epicardial pacing electrodes: six year experience of pacing thresholds in a growing pediatric population. Pacing Clin Electrophysiol 1997; 20(12 Pt 1): 2943–2948.Google Scholar
Karpawich PP, Stokes KB, Proctor K, Schallhorn R, McVenes R, Factkor M. Improved epimyocardial pacing: initial experience with a new bipolar, steroid-eluting, high impedance lead design. Pacing Clin Electrophysiol 1994; 17(11 Pt 2): 2032–2037.Google Scholar
Bristow MR, Saxon LA, Boehmer J, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. [see comment]. New Engl J Med 2004; 350: 2140–2150.Google Scholar
Cleland JG, Daubert JC, Erdmann E, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. [see comment]. New Engl J Med 2005; 352: 1539–1549.Google Scholar
Janousek J, Vojtovic P, Hucin B, et al. Resynchronization pacing is a useful adjunct to the management of acute heart failure after surgery for congenital heart defects. Am J Cardiol 2001; 88: 145–152.Google Scholar
Zimmerman FJ, Starr JP, Koenig PR, Smith P, Hijazi ZM, Bacha EA. Acute hemodynamic benefit of multisite ventricular pacing after congenital heart surgery. Ann Thorac Surg 2003; 75: 1775–1780.Google Scholar
Pham PP, Balaji S, Shen I, Ungerleider R, Li X, Sahn DJ. Impact of conventional versus biventricular pacing on hemodynamics and tissue Doppler imaging indexes of resynchronization postoperatively in children with congenital heart disease. [see comment]. J Am Coll Cardiol 2005; 46: 2284–2289.Google Scholar
Dubin AM, Feinstein JA, Reddy VM, Hanley FL, Van Hare GF, Rosenthal DN. Electrical resynchronization: a novel therapy for the failing right ventricle. [see comment]. Circulation 2003; 107: 2287–2289.Google Scholar
Strieper M, Karpawich P, Frias P, et al. Initial experience with cardiac resynchronization therapy for ventricular dysfunction in young patients with surgically operated congenital heart disease. Am J Cardiol 2004; 94: 1352–1354.Google Scholar
Janousek J, Tomek V, Chaloupecky VA, et al. Cardiac resynchronization therapy: a novel adjunct to the treatment and prevention of systemic right ventricular failure. J Am Coll Cardiol 2004; 44: 1927–1931.Google Scholar
Khairy P, Fournier A, Thibault B, Dubuc M, Therien J, Vobecky SJ. Cardiac resynchronization therapy in congenital heart disease. Int J Cardiol 2005; 109: 160–168.Google Scholar
Dubin AM, Janousek J, Rhee E, et al. Resynchronization therapy in pediatric and congenital heart disease patients: an international multicenter study. J Am Coll Cardiol 2005; 46: 2277–2283.Google Scholar
Alexander ME, Cecchin F, Walsh EP, Triedman JK, Bevilacqua LM, Berul CI. Implications of implantable cardioverter defibrillator therapy in congenital heart disease and pediatrics. [see comment]. J Cardiovasc Electrophysiol 2004; 15: 72–76.Google Scholar
Korte T, Koditz H, Niehaus M, Paul T, Tebbenjohanns J. High incidence of appropriate and inappropriate ICD therapies in children and adolescents with implantable cardioverter defibrillator. Pacing Clin Electrophysiol 2004; 27: 924–932.Google Scholar
Shah M ZI, Rossano J, Tanel R, Rhodes L. Comparision of implantable cardioverter-defibrillator therapy in primary vs. secondary prevention of sudden cardiac death in young patients. Circulation 2004: 110.Google Scholar
Stephenson EA C-MC, Alexander ME, Cecchin F, et al. Efficacy and complications of ICD therapy stratified by indication in the pediatrics and congenital heart disease population. Heart Rhythm 2005; 2 (1S): S55.Google Scholar
Love BA, Barrett KS, Alexander ME, et al. Supraventricular arrhythmias in children and young adults with implantable cardioverter defibrillators. J Cardiovasc Electrophysiol 2001; 12: 1097–1101.Google Scholar
Cooper JM, Stephenson EA, Berul CI, Walsh EP, Epstein LM. Implantable cardioverter defibrillator lead complications and laser extraction in children and young adults with congenital heart disease: implications for implantation and management. J Cardiovasc Electrophysiol 2003; 14: 344–349.Google Scholar
Stephenson EA, Cecchin F, Walsh EP, Berul CI. Utility of routine follow-up defibrillator threshold testing in congenital heart disease and pediatric populations. J Cardiovasc Electrophysiol 2005; 16: 69–73.Google Scholar
Berul CI, Triedman JK, Forbess J, et al. Minimally invasive cardioverter defibrillator implantation for children: an animal model and pediatric case report. Pacing Clin Electrophysiol 2001; 24: 1789–1794.Google Scholar
Gradaus R, Hammel D, Kotthoff S, Bocker D. Nonthoracotomy implantable cardioverter defibrillator placement in children: use of subcutaneous array leads and abdominally placed implantable cardioverter defibrillators in children. [see comment]. J Cardiovasc Electrophysiol 2001; 12: 356–360.Google Scholar
Thogersen AM, Helvind M, Jensen T, Andersen JH, Jacobsen JR, Chen X. Implantable cardioverter defibrillator in a 4-month-old infant with cardiac arrest associated with a vascular heart tumor. Pacing Clin Electrophysiol 2001; 24: 1699–1700.Google Scholar
Stephenson EA, Batra AS, Knilans TK, et al. A multicenter experience with novel implantable cardioverter defibrillator configurations in the pediatric and congenital heart disease population. J Cardiovasc Electrophysiol 2006; 17: 41–46.Google Scholar
Wathen MS, DeGroot PJ, Sweeney MO, et al. Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: Pacing fast ventricular tachycardia reduces shock therapies (PainFREE Rx II) trial results. Circulation 2004; 110: 2591–2596.Google Scholar
Wathen MS, Sweeney MO, DeGroot PJ, et al. Shock reduction using antitachycardia pacing for spontaneous rapid ventricular tachycardia in patients with coronary artery disease. Circulation 2001; 104: 796–801.Google Scholar
DeMaso DR, Lauretti A, Spieth L, et al. Psychosocial factors and quality of life in children and adolescents with implantable cardioverter-defibrillators. Am J Cardiol 2004; 93: 582–587.Google Scholar
Garson A, Jr., Bink-Boelkens M, Hesslein PS, et al. Atrial flutter in the young: a collaborative study of 380 cases. J Am Coll Cardiol 1985; 6: 871–878.Google Scholar
Gelatt M, Hamilton RM, McCrindle BW, et al. Arrhythmia and mortality after the Mustard procedure: a 30-year single-center experience. J Am Coll Cardiol 1997; 29: 194–201.Google Scholar
Gelatt M, Hamilton RM, McCrindle BW, et al. Risk factors for atrial tachyarrhythmias after the Fontan operation. J Am Coll Cardiol 1994; 24: 1735–1741.Google Scholar
Puley G, Siu S, Connelly M, et al. Arrhythmia and survival in patients >18 years of age after the mustard procedure for complete transposition of the great arteries. Am J Cardiol 1999; 83: 1080–1084.Google Scholar
Stephenson EA, Casavant D, Tuzi J, et al. Efficacy of atrial antitachycardia pacing using the Medtronic AT500 pacemaker in patients with congenital heart disease. Am J Cardiol 2003; 92: 871–876.Google Scholar